Intrexon Corp. (NYSE:XON) was up 2.9% during trading on Wednesday . The stock traded as high as $29.50 and last traded at $29.42, with a volume of 1,262,217 shares changing hands. The stock had previously closed at $28.58.

Several equities research analysts have recently commented on XON shares. Vetr upgraded shares of Intrexon Corp. from a “hold” rating to a “strong-buy” rating and set a $33.69 price target for the company in a report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of Intrexon Corp. from a “hold” rating to a “buy” rating and set a $29.00 price target for the company in a report on Tuesday, July 19th. Stifel Nicolaus restated a “buy” rating on shares of Intrexon Corp. in a report on Thursday, April 21st. Wunderlich restated a “buy” rating and issued a $50.00 price target on shares of Intrexon Corp. in a report on Thursday, July 7th. Finally, Griffin Securities restated a “buy” rating and issued a $55.00 price target on shares of Intrexon Corp. in a report on Tuesday. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $41.71.

The firm has a 50 day moving average of $26.03 and a 200-day moving average of $29.77. The company’s market cap is $3.46 billion.

Intrexon Corp. (NYSE:XON) last announced its earnings results on Tuesday, August 9th. The company reported ($0.42) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.26) by $0.16. During the same period in the previous year, the business posted ($0.37) earnings per share. The business had revenue of $52.50 million for the quarter, compared to the consensus estimate of $53.78 million. Intrexon Corp.’s revenue for the quarter was up 17.0% compared to the same quarter last year. On average, analysts expect that Intrexon Corp. will post ($1.35) earnings per share for the current year.

A number of hedge funds and institutional investors recently made changes to their positions in the company. Trexquant Investment LP bought a new position in shares of Intrexon Corp. during the fourth quarter valued at $2,590,000. Swiss National Bank raised its position in shares of Intrexon Corp. by 3.8% in the fourth quarter. Swiss National Bank now owns 62,500 shares of the company’s stock valued at $1,884,000 after buying an additional 2,300 shares during the period. Rhumbline Advisers raised its position in shares of Intrexon Corp. by 6.7% in the fourth quarter. Rhumbline Advisers now owns 46,016 shares of the company’s stock valued at $1,387,000 after buying an additional 2,890 shares during the period. State of Wisconsin Investment Board raised its position in shares of Intrexon Corp. by 2.5% in the fourth quarter. State of Wisconsin Investment Board now owns 35,410 shares of the company’s stock valued at $1,068,000 after buying an additional 880 shares during the period. Finally, Bank of Montreal Can raised its position in shares of Intrexon Corp. by 16.8% in the fourth quarter. Bank of Montreal Can now owns 40,010 shares of the company’s stock valued at $1,207,000 after buying an additional 5,742 shares during the period.

Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.